Both methods of metformin and rifampicin combined treatment reduced skin lesions size, skin disease score, TNF-α expression and pathological damage to a greater extent than rifampicin therapy alone by day 26 in a recurrent skin infection (Fig 7B–7D and 7I). The gene discussed is TNF; the disease is skin infection.